Drug companies’ price transparency reports paint murky picture
Over the past decade, pharmaceutical companies have released carefully curated “price transparency” reports that make it appear the prices of their medicines are barely increasing — or even going down. But the reports disclose no pricing information about specific drugs, manipulating the reality of how much Americans spend on prescription drugs. If anything, experts say,…
